Eisler Capital (US)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$6.82M Buy
7,700
+2,200
+40% +$1.98M 0.15% 153
2024
Q2
$4.98M Buy
5,500
+600
+12% +$480K 0.09% 201
2024
Q1
$3.81M Buy
+4,900
New +$3.49M 0.09% 202
2023
Q4
Sell
-26,000
Closed -$14M 349
2023
Q3
$14M Buy
26,000
+1,700
+7% +$876K 0.36% 59
2023
Q2
$11.4M Buy
+24,300
New +$10.2M 0.39% 42

Other funds holding LLY

Eisler Capital (US)'s LLY Position: Q3 2024 in Review

Eisler Capital (US) opened a new position in Eli Lilly (LLY) in Q3 2024: 2,975 shares worth $2.64M. The stake represents 0.06% of the portfolio and ranks #289 among its holdings.

3,659 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • Eisler Capital (US) held 2,975 shares of Eli Lilly worth $2.64M as of Q3 2024.
  • Eli Lilly was a new Eisler Capital (US) position in Q3 2024.
  • Eli Lilly made up 0.06% of Eisler Capital (US)'s portfolio in Q3 2024, its #289 holding.
  • 3,659 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.